Geiger K, Patil A, Budhathoki C, Dooley KE, Lowensen K, Ndjeka N, Ngozo J, Farley JE. Relationship between HIV viral suppression and multidrug resistant tuberculosis treatment outcomes. PLOS Glob Public Health. 2024 May 6;4(5):e0002714. doi: 10.1371/journal.pgph.0002714. PMID: 38709764; PMCID: PMC11073678.
Archives: Publications
Publications
A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice
Shaku MT, Um PK, Ocius KL, Apostolos AJ, Pires MM, Bishai WR, Kana BD. A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice. Elife. 2024 Apr 19;13:e89157. doi: 10.7554/eLife.89157. PMID: 38639995; PMCID: PMC11132681.
Restocking the tuberculosis drug arsenal
Nuermberger, E.L., Chaisson, R.E. Restocking the tuberculosis drug arsenal. Nat Med 30, 642–643 (2024). https://doi.org/10.1038/s41591-024-02840-y
The magnitude of unfavorable tuberculosis treatment outcomes and their relation with baseline undernutrition and sustained undernutrition among children receiving tuberculosis treatment in central Ethiopia
Burusie A, Enquesilassie F, Salazar-Austin N, Addissie A. The magnitude of unfavorable tuberculosis treatment outcomes and their relation with baseline undernutrition and sustained undernutrition among children receiving tuberculosis treatment in central Ethiopia. Heliyon. 2024;10(6):e28040. Published 2024 Mar 16. doi:10.1016/j.heliyon.2024.e28040
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
Krishnan S, Chaisson RE. US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy. Clin Infect Dis. 2024;78(3):514-517. doi:10.1093/cid/ciad659
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester
Gupta A, Hughes MD, Cruz JL, et al. Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester. Clin Infect Dis. 2024;78(3):667-673. doi:10.1093/cid/ciad583
What is next for BCG revaccination to prevent tuberculosis?
White RG, Fiore-Gartland AJ, Hanekom WA, et al. What is next for BCG revaccination to prevent tuberculosis?. Lancet Respir Med. 2024;12(3):e7-e8. doi:10.1016/S2213-2600(24)00009-2
Factors associated with non-completion of TB preventive treatment in Brazil
Cola JP, Nascimento do Prado T, Alves KBA, et al. Factors associated with non-completion of TB preventive treatment in Brazil. Int J Tuberc Lung Dis. 2023;27(3):215-220. doi:10.5588/ijtld.22.0571
Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa
McNabb KC, Bergman AJ, Patil A, et al. Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa. BMC Public Health. 2024;24(1):578. Published 2024 Feb 23. doi:10.1186/s12889-024-17924-0
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial
Semitala FC, Kadota JL, Musinguzi A, et al. Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial. PLoS Med. 2024;21(2):e1004356. Published 2024 Feb 20. doi:10.1371/journal.pmed.1004356